{
    "clinical_study": {
        "@rank": "51944", 
        "arm_group": [
            {
                "arm_group_label": "Control group", 
                "arm_group_type": "No Intervention", 
                "description": "Conventional treatment with no probiotic supplementation"
            }, 
            {
                "arm_group_label": "Probiotic group", 
                "arm_group_type": "Experimental", 
                "description": "The patients received one oral lyophilized yeast capsule, each of which contains 100 mg (0,5 x 109 cfu/g) of Saccharomyces boulardii (Merck S.A., Biocodex, Beauvais, French), once a day. The treatment started at least seven days before surgery and stopped on the operation day."
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators would study about impact of the administration of probiotics in the\n      intestinal mucosa of patients undergoing resection colic, by evaluating cytokine profile by\n      quantitative real time PCR. The investigators believe that patients who use probiotic\n      preoperative would provide cytokine profile less inflammatory than those of the control\n      group."
        }, 
        "brief_title": "Impact of Probiotics in Modulation of Intestinal Microbiota", 
        "completion_date": {
            "#text": "May 2012", 
            "@type": "Actual"
        }, 
        "condition": "Colorectal Cancer", 
        "condition_browse": {
            "mesh_term": "Colorectal Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "Samples of colorectal cancer-free mucosa derived from patients who underwent surgical\n      resection were investigated. Quantitative real-time polymerase chain reaction (RT-qPCR) was\n      used to determine expression levels of the following genes: IL10, IL1B, IL23A, TNF, IL12B,\n      INFG, IL17A."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  if he or she were older than 18 years\n\n          -  intended to undergo elective CRC resection at UFMG Hospital\n\n        Exclusion Criteria:\n\n          -  Patients were excluded if they were not able to receive the probiotics seven days\n             before the operation\n\n          -  if colon resection was not performed due to changes in operation strategy, or if they\n             discontinued probiotic use on their own or\n\n          -  if they removed their consent."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "33", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01895530", 
            "org_study_id": "ETIC 0391.0.203.000-09"
        }, 
        "intervention": {
            "arm_group_label": "Probiotic group", 
            "description": "The patients received one oral lyophilized yeast capsule, each of which contains 100 mg (0,5 x 109 cfu/g) of Saccharomyces boulardii (Merck S.A., Biocodex, Beauvais, French), once a day. The treatment started at least seven days before surgery and stopped on the operation day.", 
            "intervention_name": "Saccharomyces boulardii", 
            "intervention_type": "Dietary Supplement"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Probiotics", 
            "colorectal cancer", 
            "postoperative infection", 
            "immune function", 
            "bacterial translocation", 
            "gastrointestinal surgery"
        ], 
        "lastchanged_date": "July 5, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Belo horizonte", 
                    "country": "Brazil", 
                    "state": "Minas Gerais", 
                    "zip": "30640100"
                }, 
                "name": "UFMG Hospital"
            }
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "2", 
        "official_title": "Impact of Probiotics in Modulation of Intestinal Microbiota of Patients Undergoing a Resection Colonic", 
        "overall_official": {
            "affiliation": "Federal University of Minas Gerais", 
            "last_name": "Isabel TD Correia, PhD", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Brazil: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Colonic mucosal specimens were analyzed to determine the mucosal expression pro\ufb01les of IL1B, IL12B, IL10, IL23A, INFG, IL17A and TNF.", 
            "measure": "Difference in gene expression of citokynes", 
            "safety_issue": "No", 
            "time_frame": "15 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01895530"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Federal University of Minas Gerais", 
            "investigator_full_name": "Maria Isabel Toulson Davisson Correia", 
            "investigator_title": "PhD.", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "description": "Postoperative complications assessed up to 30 days", 
            "measure": "Postoperative complications", 
            "safety_issue": "No", 
            "time_frame": "30 days"
        }, 
        "source": "Federal University of Minas Gerais", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Maria Isabel Toulson Davisson Correia", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2010", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}